Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
59.5M
-
Shares change
-
+1.85M
-
Total reported value, excl. options
-
$4.34B
-
Value change
-
+$149M
-
Put/Call ratio
-
0.23
-
Number of buys
-
133
-
Number of sells
-
-71
-
Price
-
$73.11
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q2 2020
255 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q2 2020.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.5M shares
.
Largest 10 shareholders include Capital International Investors (6.01M shares), BlackRock Inc. (3.53M shares), MARSHALL WACE, LLP (2.5M shares), STIFEL FINANCIAL CORP (2.49M shares), Capital World Investors (2.2M shares), RP Management, LLC (2.11M shares), WELLINGTON MANAGEMENT GROUP LLP (2.08M shares), ORACLE INVESTMENT MANAGEMENT INC (2.01M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.78M shares), and STATE STREET CORP (1.77M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.